Home/Pipeline/IONIS-FB-LRx

IONIS-FB-LRx

Geographic Atrophy (GA)

Phase 3Active

Key Facts

Indication
Geographic Atrophy (GA)
Phase
Phase 3
Status
Active
Company

About Ionis Pharmaceuticals

Ionis Pharmaceuticals is a commercial-stage biotech leader with a mission to discover and deliver life-changing RNA-targeted medicines. The company has achieved multiple industry firsts, including the first approved antisense drug, and has successfully transitioned from a research-focused entity to a fully integrated organization with its own commercial capabilities. Its strategy centers on independently launching medicines in neurology and cardiology while selectively partnering in other areas, backed by a deep, late-stage pipeline and a sustainable technology platform.

View full company profile

Other Geographic Atrophy (GA) Drugs

DrugCompanyPhase
NGM621NGM BiopharmaceuticalsPhase 2
K8 ImplantInflammasome TherapeuticsPhase I/II
ANX007Annexon BiosciencesPhase 2/3